Alcohol and Metabolic-associated Fatty Liver Disease

被引:10
|
作者
Sun, Fu-Rong [1 ]
Wang, Bing-Yuan [1 ]
机构
[1] China Med Univ, Dept Elderly Gastroenterol, First Hosp, Shenyang, Liaoning, Peoples R China
关键词
Alcohol; Metabolic-associated fatty liver disease; Obesity; Insulin resistance; Hypertension; CARDIOVASCULAR RISK-FACTORS; HIGH-DENSITY-LIPOPROTEINS; KOREA NATIONAL-HEALTH; BODY-MASS INDEX; BLOOD-PRESSURE; INSULIN SENSITIVITY; RED WINE; BEVERAGE CONSUMPTION; CHINESE POPULATION; ACID METABOLISM;
D O I
10.14218/JCTH.2021.00173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The diagnosis of metabolic-associated fatty liver disease is based on the detection of liver steatosis together with the presence of metabolic dysfunction. According to this new defi-nition, the diagnosis of metabolic-associated fatty liver disease is independent of the amount of alcohol consumed. Actually, alcohol and its metabolites have various effects on metabolic-associated abnormalities during the process of alcohol me-tabolism. Studies have shown improved metabolic function in light to moderate alcohol drinkers. There are several studies focusing on the role of light to moderate alcohol intake on metabolic dysfunction. However, the results from studies are diverse, and the conclusions are often controversial. This re-view systematically discusses the effects of alcohol consump-tion, focusing on light to moderate alcohol consumption, on obesity, lipid and glucose metabolism, and blood pressure. Citation of this article: Sun FR, Wang BY. Alcohol and metabolic-associated fatty liver disease. J Clin Transl Hepa-tol 2021. doi: 10.14218/JCTH.2021.00173.
引用
收藏
页码:719 / 730
页数:12
相关论文
共 50 条
  • [21] Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome
    Kawada, Tomoyuki
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2435 - 2435
  • [22] Metabolic-Associated Fatty Liver Disease and Diabetes A Double Whammy
    Kapoor, Nitin
    Kalra, Sanjay
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (03) : 469 - 484
  • [23] Metabolic-associated fatty liver disease and sarcopenia: A double whammy
    Viswanath, Aditya
    Fouda, Sherouk
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (02) : 152 - 163
  • [24] Roles of gut microbes in metabolic-associated fatty liver disease
    Chen, Chun-Yao
    Ho, Han-Chen
    TZU CHI MEDICAL JOURNAL, 2023, 35 (04): : 279 - 289
  • [25] METABOLIC-ASSOCIATED FATTY LIVER DISEASE AND SARCOPENIA: A SYSTEMATIC REVIEW
    Fouda, S.
    Pappachan, J. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S559 - S560
  • [26] Management of metabolic-associated fatty liver disease: The diabetology perspective
    Jeeyavudeen, Mohammad Sadiq
    Khan, Shahanas K. A.
    Fouda, Sherouk
    Pappachan, Joseph M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (01) : 126 - 143
  • [27] Management of metabolic-associated fatty liver disease: The diabetology perspective
    Mohammad Sadiq Jeeyavudeen
    Shahanas K A Khan
    Sherouk Fouda
    Joseph M Pappachan
    World Journal of Gastroenterology, 2023, 29 (01) : 126 - 143
  • [28] Editorial: Exercise, diabetes and metabolic-associated fatty liver disease
    Sun, Yang
    Sun, Chao
    Hu, Gang
    Shen, Yun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [29] Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
    Fouda, Sherouk
    Vennikandam, Madhu Mathew
    Pappachan, Joseph M.
    Fernandez, Cornelius J.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 947 - 954
  • [30] Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease
    Zhang, Daya
    Wang, Qi
    Li, Da
    Chen, Shiju
    Chen, Jinrun
    Zhu, Xuli
    Bai, Feihu
    VIRULENCE, 2025, 16 (01)